“…The early stages of inflammation are proinflammatory states mediated by inflammatory factors such as tumor necrosis factor alpha (TNF-α), interleukin-1, and interleukin-6, which are released by neutrophils, macrophages, and monocytes ( 13 , 14 ). LMR is a widely used marker for the assessment of tumor-associated inflammation and a prognostic indicator of malignant tumors ( 15 - 17 ). In addition, studies have shown that the decline of LMR is related to systemic inflammatory responses.…”